Geneva, July 7 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000062030) titled 'Prediction and Assessment of Hepatitis B Virus Reactivation Risk Under Immunosuppressive Therapy' on June 23.

Study Type: Observational

Study Design: Not selected Not selected

Primary Sponsor: Kyoto University

Condition: HBV reactivation

Recruitment Status: Not Recruiting

Phase: Not applicable

Date of First Enrollment: 2026/06/23

Target Sample Size: 300

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070981

Published by HT Digital Content Services with permission from Health Daily Digest....